We are live on
!
Find out more
EARNEST Partners Portfolio holdings
AUM
$27.7B
Turnover
6.77%
1-Year Est. Return
52.44%
This Fund
S&P 500
This Quarter
Est. Return
+7.57%
1 Year Est. Return
+52.44%
3 Year Est. Return
+92.17%
5 Year Est. Return
+120.28%
10 Year Est. Return
+519.8%
AUM
$10B
AUM Growth
+$518M
(+5.4%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
18.87%
Holding
233
New
8
Increased
78
Reduced
133
Closed
4
Avg Time Held
3.1
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Darling Ingredients
DAR
|
+$67.4M |
| 2 |
EastGroup Properties
EGP
|
+$40.3M |
| 3 |
PENN Entertainment
PENN
|
+$33.5M |
| 4 |
Arrow Electronics
ARW
|
+$32M |
| 5 |
Avnet
AVT
|
+$17.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$99.4M |
| 2 |
TSMC
TSM
|
+$29.1M |
| 3 |
FPO
First Potomac Realty Trust
FPO
|
+$24.9M |
| 4 |
Icon
ICLR
|
+$16.9M |
| 5 |
VWR
VWR Corporation
VWR
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.16% |
| 2 | Industrials | 19.65% |
| 3 | Technology | 15.19% |
| 4 | Healthcare | 13.48% |
| 5 | Consumer Discretionary | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
DELISTED
Ansys
ANSS
| $33.7M | 0.34% |
274,792
-5,725
| -2% | -$719K |
2013 Q4
15 quarters
|
|
|
102
Arrow Electronics
ARW
$11B
| $32.6M | 0.32% |
+405,266
| New | +$32M |
2017 Q3
0 quarters
|
|
|
TSS
103
DELISTED
Total System Services, Inc.
TSS
| $32.4M | 0.32% |
495,197
-21,681
| -4% | -$1.4M |
2016 Q2
5 quarters
|
|
104
Humana
HUM
$52.3B
| $32.3M | 0.32% |
132,432
-7,333
| -5% | -$1.8M |
2013 Q4
15 quarters
|
|
105
Synchrony
SYF
$23.7B
| $32.2M | 0.32% |
1,035,791
-43,063
| -4% | -$1.29M |
2016 Q1
6 quarters
|
|
|
BKI
106
DELISTED
Black Knight, Inc. Common Stock
BKI
| $30.4M | 0.3% |
705,895
-24,575
| -3% | -$1.04M |
2016 Q2
5 quarters
|
|
107
Charles River Laboratories
CRL
$14.6B
| $28.3M | 0.28% |
262,262
+20,683
| +9% | +$2.12M |
2016 Q4
3 quarters
|
|
108
Woodward
WWD
$19.5B
| $26.2M | 0.26% |
337,968
-8,089
| -2% | -$570K |
2015 Q4
7 quarters
|
|
109
Alexandria Real Estate Equities
ARE
$7.32B
| $26.2M | 0.26% |
220,058
+2,940
| +1% | +$353K |
2014 Q3
12 quarters
|
|
110
Jabil
JBL
$29.7B
| $25.7M | 0.26% |
898,789
-34,859
| -4% | -$1.05M |
2016 Q4
3 quarters
|
|
111
DELISTED
Newfield Exploration
NFX
| $25.6M | 0.26% |
862,684
+3,292
| +0.4% | +$88.4K |
2013 Q4
15 quarters
|
|
112
Bio-Rad Laboratories Class A
BIO
$9.78B
| $25.5M | 0.25% |
114,771
-2,458
| -2% | -$553K |
2013 Q4
15 quarters
|
|
113
DELISTED
Gulfport Energy Corp.
GPOR
| $25.4M | 0.25% |
1,774,085
-2,847
| -0.2% | -$37K |
2016 Q1
6 quarters
|
|
114
Dentsply Sirona
XRAY
$1.75B
| $25.2M | 0.25% |
421,035
-1,418
| -0.3% | -$84.3K |
2015 Q1
10 quarters
|
|
115
Morgan Stanley
MS
$282B
| $25M | 0.25% |
518,573
-34,278
| -6% | -$1.59M |
2013 Q4
15 quarters
|
|
116
Packaging Corp of America
PKG
$20.7B
| $24.5M | 0.24% |
214,010
-5,331
| -2% | -$596K |
2015 Q3
8 quarters
|
|
117
Agilent Technologies
A
$49.4B
| $24.3M | 0.24% |
378,180
-9,415
| -2% | -$586K |
2013 Q4
15 quarters
|
|
|
CLR
118
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $24.1M | 0.24% |
624,375
-28,331
| -4% | -$962K |
2016 Q1
6 quarters
|
|
119
UnitedHealth
UNH
$371B
| $24.1M | 0.24% |
123,063
-6,024
| -5% | -$1.16M |
2013 Q4
15 quarters
|
|
120
Ryder
R
$9.13B
| $23.5M | 0.23% |
277,591
+5,059
| +2% | +$383K |
2013 Q4
15 quarters
|
|
121
Boston Properties
BXP
$9.37B
| $23M | 0.23% |
187,438
-7,994
| -4% | -$968K |
2013 Q4
15 quarters
|
|
122
WEC Energy
WEC
$34.6B
| $22.9M | 0.23% |
364,098
-8,271
| -2% | -$528K |
2015 Q2
9 quarters
|
|
123
Labcorp
LH
$26.1B
| $22.7M | 0.23% |
174,846
-4,157
| -2% | -$554K |
2015 Q1
10 quarters
|
|
124
Norfolk Southern
NSC
$72.5B
| $22.5M | 0.22% |
170,353
-10,433
| -6% | -$1.27M |
2013 Q4
15 quarters
|
|
125
Elevance Health
ELV
$93.1B
| $22.4M | 0.22% |
118,067
-8,013
| -6% | -$1.53M |
2013 Q4
15 quarters
|
|
Similar funds
EARNEST Partners's Q3 2017 Portfolio in Review
As of Q3 2017, EARNEST Partners held 233 positions worth $10B, up 5.4% from $9.52B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
EARNEST Partners's Q3 2017 filing shows 8 new, 78 increased, 133 reduced and 4 closed positions. Its largest new stake was Darling Ingredients: 3,984,504 shares worth $69.8M. The largest sale was Teva Pharmaceutical Industries Limited, an estimated $99.4M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.
- EARNEST Partners's largest Q3 2017 buy was Darling Ingredients: 3,984,504 shares worth $69.8M.
- EARNEST Partners added most to Core Laboratories in Q3 2017, an estimated $11.2M increase.
- EARNEST Partners's biggest Q3 2017 reduction was TSMC, cutting an estimated $29.1M.
- EARNEST Partners fully exited Teva Pharmaceutical Industries Limited in Q3 2017, selling an estimated $99.4M.
- EARNEST Partners's ten largest holdings make up 19% of its $10B portfolio in Q3 2017.
- EARNEST Partners opened 8 new positions and closed 4 in Q3 2017.
- EARNEST Partners's portfolio value rose 5.4% quarter-over-quarter to $10B.
Based on EARNEST Partners's 13F filing for Q3 2017, filed 14 Nov 2017.